Stockholder Equity (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended	6 Months Ended	12 Months Ended	15 Months Ended
	Feb. 05, 2022	Feb. 27, 2022	Jul. 16, 2021	Apr. 30, 2022	Apr. 30, 2022	Oct. 31, 2021	Apr. 30, 2022	Jul. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock option expense					$ 2,925,892
Additional paid-in capital				$ 4,621,710	$ 4,621,710		$ 4,621,710
Preferred stock, shares authorized				5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share								$ 0.001
Reverse stock split description					as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock
Stockholders' Equity, Reverse Stock Split			1-for-12
Exercise of common stock warrants				$ 873,286
Common Stock, Shares Authorized				1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Common Stock, Par or Stated Value Per Share				$ 0.001	$ 0.001	$ 0.001	$ 0.001
Issuance of warrants						4,053,750
Exercise price						$ 1.90
Warrants exercised				$ 1,566,190	$ 1,566,190		$ 1,566,190
Aggregate intrinsic value				0	$ 0	$ 0	0
Weighted average remaining term					4 years 6 months
Restricted stock unit awards description	the Company issued 61,250 shares of Common Stock to 7 employees in accordance with the vesting schedules set forth in RSU agreements previously entered into with such employees, resulting in the recognition of approximately $65,538 of share-based compensation. Of the shares issued to employees, 24,058 shares were withheld by the Company to satisfy tax withholding obligations and/or satisfy cash settlement options to employees, equaling approximately $24,058. On March 4, 2022, the Company’s Board approved the termination of the RSU agreements with the consent of the employees. At the time these agreements were terminated, there remained 1,230,833 unvested RSUs with approximately $4,457,875 of related unvested compensation.				the Company issued 61,250 shares of Common Stock to 7 employees in accordance with the vesting schedules set forth in RSU agreements previously entered into with such employees, resulting in the recognition of approximately $110,250 of share-based compensation. Of the shares issued to employees, 19,866 shares were withheld by the Company to satisfy tax withholding obligations and/or satisfy cash settlement options to employees, equaling approximately $35,759.
Restricted Common Stock					18,160
Stock option awards, description						the Company granted options exercisable for up to 150,000 shares of Common Stock of which 15,000 fully vested on March 17, 2021, 7,500 fully vested on June 30, 2021, 41,667 fully vested on December 1, 2021, 68,333 vested on March 17, 2022, 68,333 vest on March 17, 2023, and 17,500 vest over the next 2 years on June 30, 2022 and 2023. The options have exercise prices ranging from $9.12 to $28.68 per share. These options have a weighted average remaining life of 9.43 years as of October 31, 2021 and of 8.92 years as of April 30, 2022. The options expire in the year 2031. On July 19, 2021, two of the stock option agreements, exercisable for an aggregate of 50,000 shares of Common Stock, were modified to accelerate the full vesting period from 3 years to 2 years
Amortized expense					$ 1,044,517
Unamortized expense				1,065,217	1,065,217		1,065,217
Stock options exercised		200,000
Fair market value		$ 2.45
Amortization expense for these stock options							285,832
[custom:UnamortizedStockOptionExpense]					1,645,395		204,167
Aggregate intrinsic value				$ 0	$ 0	$ 0	$ 0
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of warrants				873,326	873,326		873,326
Common Stock Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Weighted average remaining term					4 years 6 months
Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Additional paid-in capital				$ 130,502	$ 130,502		$ 130,502
Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Additional paid-in capital				$ 1,565,316	$ 1,565,316		$ 1,565,316
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized								3,000,000
Preferred stock, shares issued				3,000,000	3,000,000		3,000,000
Preferred Stock, Shares Outstanding								3,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options exercised		100,000
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amortization expense for these stock options				$ 2,303,533
Aggregate intrinsic value				$ 0	$ 0	$ 0	$ 0